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of 30-day mortality among diabetics. Conclualone: Despite the contemporary manage- 
ment, diabetic patients wffh non-ST-segment elevation acute coronary syndromes have 
almost doubled 30-day mortality than nondiabetica. 
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9:30 a.m. 
840-5 In-Hospital Outcome of Acute Myocardial Infarction in 
Patients With Prior Coronary Artery Bypass Surgery: A 
Study From NRMI 3 
Verahese Mathew. Bernard J. Gersh, Hal Barren, Nathan Every, Alan T~efenbrunn, Paul 
Frederick, Judith Malmgren, For the NRMI Investigators, Mayo Clinic and Foundation, 
Rochester, Minnesota. 
Background: Patients with coronary artery bypass grafting (CABG) comprise an increas- 
ing proportion of acute myocardial infarction (MI) patients. Data regarding the influence 
of prior CABG on survival after MI is discordant; the influence of sinus tachycardia (ST) 
segment shift (ST elevation vs non-ST elevation) on outcome has not been examined in 
this population. We sought to describe the characteristics of patients with and without 
prior CABG presenting with acute MI, with or without ST segment elevation/left bundle 
branch block (LBBB), and to evaluate the effect of ST segment shift on in-hospital mortal- 
ity in patients with prior CABG. 
Methods: Utilizing the NRMI-3 Registry, we identified 112,697 patients with acute Mt with- 
out exclusion criteria. Of these, 15,936 (14.t%) had prior CABG. 
Results: Patients with prior CABG had more adverse baseline characteristics, and were 
less likely to present with ST elevation/LBBB than patients without prior CABG. The 
unadjusted mortality for ST elevation/LBBB patients was higher in patients with prior 
CABG compared to those without (16.2% vs 14.1%, P=0.0001) whereas in patients with- 
out ST elevation/LBBB, prior CASG patients had a lower unadjusted mortality than 
patients without prior CABG (10.1% vs 12.4%, P=0.0001). Adjusting for baseline differ- 
ences, prior CABG was weakly associated with in-hospital mortality in patients present- 
ing with ST elevation/LBBB (odds ratio (OR), 1.11, 96% confidence intervals (CI) 1.00- 
1.23), whereas prior CABG did not correlate with in-hospital mortality in patients present- 
ing without ST elevation/LBSB (OR 0.99, 96% CI 0.92-1.07). 
Conclusion: Patients with prior CABG who present with acute MI are more likely to 
present without ST etevation/LBBB, as compared to patients without phor CABG. Prior 
CABG was weakly associated with in-hospital mortality in patients with ST elevation/ 
LBBB, but did not influence in-hospital mortality in patients without these electrocardio- 
graphic findings. This suggests the difference in absolute mortality rates between 
patients presenting with MI with and without a history of prior CABG are in large part due 
to differences in baseline characteristics, 
9:45 a.rn. 
840-6 Cardiovascular Manifestations of Carbon Monoxide 
Poisoning 
Daniel Satran. Christopher R. Henry, Caren I. Chaney, Cheryl D. Adkinson, Timothy D. 
Henry, Hennepin County Medical Center, Minneapolis, Minnesota, University of 
Minnesota, Minneapolis, Minnesota. 
Carbon monoxide (CO) poisoning is a common cause of morbidity and mortality. While 
the neurologic sequelae of CO poisoning have been described, the cardiovascular com- 
plications are limited to isolated case reports. Methods: We reviewed the cardiovascular 
manifestations of 216 consecutive patients(Pts) treated for severe CO poisoning in the 
hyperbaric oxygen chamber at Hennepin County Medical Center, a regional center for 
treatment of CO poisoning. Results: The mean age was 47.2 years. 35 (16.4%) Pts had a 
normal baseline EKG; 94 (44.1%) sinus tachycardia; 85 (39.9%) non-specific ST 
changes; 63 (29.6%) ischemic changes, including 53 (24.8%) with dynamic ST or T wave 
changes and 10 (4.7%) with ST elevation. Of the 171 pts with cardiac enzymes, 75 
(34.7% of the total) were diagnostic of myocardial injury (CK-MB mass >5.0 ng/ml or 
troponin I >0.7 ng/ml). An additional 4 pts had EKG changes diagnostic of myocardial 
injury, but without cardiac enzymes. Of the 49 pts with echocardiograms, 27 (55.1%) had 
decreased left ventricular (LV) function. Of those 27, 14 had global wall motion abnormal- 
ity (WMA), and 13 had regional WMA. An additional 16 had RV dysfunction. In hospital 
mortality was only 3.7% (n=8), the most common cause being anoxic brain and burn 
injury (n=5). 3 Pts had an out of hospital cardiac arrest leading to anoxic brain injury and 
death. Two clear patterns of myocardial injury were identified. Older Pts with cardiac risk 
factors or previous CAD were more likely to have regional WMA with myocardial injury 
related to CAD. In contrast, another group was younger, without evidence of CAD, and 
more likely to have reversible global LV dysfunction. Conclusions: This is the first system- 
atic description of cardiovascular manifestations of CO poisoning. Cardiovascular 
sequelae of severe CO poisoning are frequent (36.6% with myocardial injury) and often 
unrecognized but mortality is related to noncardiac causes. Pts admitted with severe CO 
poisoning should have a baseline EKG and serial cardiac enzymes. Pts with EKG 
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changes or elevated enzymes should have an echocardiogram. Pts with myocardial 
injury in association with cardiac risk factors, previous CAD or persistent LV dysfunction 
deserve further evaluation. 
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841-1 Outcome After Acute Myocardial Infarction In Young 
Patients: Analysis of the PAMI Database 
Roberto A. Comus. Jr., Judith A. Boura, Gregg W. Stone, Bruce R. Brodie, David A. Cox, 
Eulogio Garcia, Lori L Grines, William W. O'Neill, Cindy L. Grines, William Beaumont 
Hospital, Royal Oak, Michigan. 
Background: Acute myocardial infarction (AMI) in patients (pts) < 40 years old (y/o) is 
uncommon. Few data exist regarding the outcome of these pts after percutaneous inter- 
vention (PCI) for AMI. 
Methods: This analysis pooled pts from 7 PAMI studies for a total of 4017 pts. Pts < 40 y/ 
o (N=171) were compared to pts > 40 y/o (N=3846). In-hospital, 6 month and 1 year out- 
comes are reported. 
Results: Younger pts were more often male and had a significantly higher incidence of 
smoking and family history of CAD, but a lower incidence of hypertension, diabetes, 
stroke, and prior coronary intervention compared to pts > 40 y/o. Younger pts had larger 
infarct sizes as measured by peak CPK (2974 vs. 2016, p=0.003) but no significant differ- 
ence in ejection fraction at baseline (50% vs. 48%) or 6 months (54% vs. 55%) compared 
to older pts. Younger pts had less muitivessel disease (p<0.001) and greater achieve- 
ment of TIMI 3 flow (99% vs. 92%, p=0.006) after PCI. While pts < 40 y/o had less mor- 
tality compared to older pts, recurrent AMI was significantly higher in the younger 
population (p=0.012). 
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In multivariate analysis, age _< 40 was the most significant predictor of re-infarction at 1 
year (OR=3.62 [95%C1: 1.794-7.296], p=0.0003. 
Conclusions: While pts _< 40 years old have improved survival after AMI, they have an 
increased rate of nonfatal re-infarction at 1 year compared to older pts. These data sug- 
gest the need for comprehensive diagnostic evaluation, aggressive nsk factor modifica- 
tion, and intensive follow-up in young pts with AMI. 
8:45 a.m. 
841-2 Interleukln-1 Beta Predicts Death or Myocardial 
Infarction Independently of High-Sensitivity C-Reactive 
Protein and Standard Risk Factors in Patients With 
Coronary Artery Disease 
Jason M. Laooe'. Joseph B. Muhlestein, John F. Cadquist, Brent P. Davis, Benjamin D. 
Home, Jeffrey L. Anderson, LDS Hospital, Salt Lake City Utah, University of Utah, Salt 
Lake City, Utah. 
Background: Intarleukin (IL)-I beta, tumor necrosis factor alpha (TNFalpha) and IL-6 
are important proinflammatory cytokines. IL-6 is produced in response to ~L-1 and TNFal- 
pha and is one of the major inducers of C-reactive protein (CRP). Elevated high-sensitiv- 
ity (hs)CRP is associated with an increased risk of death and MI in patients with 
CAD.The objective of this study was to determine whether IL-1, IL-6 or TNFalpha also 
independently predict death or MI in CAD patients. 
Methods: A nested case control study evaluating levels of IL-1 beta, IL-6, TNFalpha, and 
hsCRP (measured on the automated DPC Immulita platform) in 334 patients with signifi- 
cant, angiographically-proven coronary artery disease (>1 lesion of ->70% stenosis) was 
performed. Overall, 167 patients died or had an MI (cases), and 167 patients were event- 
free (controls). Cases were matched 1:1 to controls by age, gender, and time period of 
angiogram. Other cardiovascular hsk factors were recorded and patients followed for 
3.6~O.75 years (range: 2.0-5.0 years). 
Results: Average age was 69.6+9.9 years and 74% of patients were male. In multivad- 
able Cox regression controlling for 11 co-variables, hsCRP (hazard ratio [HR]= 1.24 per 
tertile, 95% confidence interval [CI]= 1.02-1.5, p=0.03) and IL-1 beta (HR=1.32 per tartile, 
CI= 1.08-1.6, p=0.008) were independently predictive of deatWIVll, but IL-6 (p=0.36, 
tracked with hsCRP) and TNFalpha (p=0.97) did not predict events. IL-6 and hsCRP 
were mildly correlated (r=0.38) and IL-1 beta nominally correlated with TNFalpha 
(r=0.24). No cytokine nor hsCRP was correlated with cholestarol evels. When analyzed 
jointly, having a high hsCRP (tertile 2,3) and high IL-1 beta (tertile 3) predicted a marked 
increase in events (HR=5.3, p<0.001) compared to low hsCRP (tertile 1) and low IL-1 
beta (tertile 1). 
JACC March 6, 2002 
Conclusion: In addition to the predictive value of hsCRP, concentrations of IL-1 beta sig- 
nificantly and independently predicted a step-wise increase in the risk of death or MI. The 
mechanism for CAD risk associated with IL-1 beta independent of IL-6 and hsCRP is 
unknown but suggests complex in rive regulatory networks. Larger studies are needed to 
confirm this finding and to evaluate its implications. 
9:00 a.m. 
841-3 The Combination of Troponin and CRP Levels at 
Admission: A Strong Prognostic Indicator of One-Year 
Morta l i ty  in Both Men and Women With Unstab le  
Coronary Artery Disease 
Stefan K. James. Paul Armstrong, Rob Califf, Agneta Siegbahn, Maarten Simocns, Lars 
Wallentin, the GUSTO-IV trialists, Thoraxcenter, Uppsala, Sweden. 
Background: In acute coronary syndrome (ACS) inflammatory activity and myocardial 
damage as indicated by elevation of the C-reactive protein (CRP) and Troponin T(TnT) 
levels are associated with an impaired clinical outcome. 
Methods: The GUSTO IV ACS trial, evaluating the efficacy of abciximab as the primary 
medical treatment in ACS without early revascularization, included 7800 patients with 
chest pain within 24 hours and either ST-segment depression or elevation of troponin at 
entry. CRP and TnT at randomization from 7108 patients (91%) were determined at the 
core laboratory. CRP (-<1.64, 1.84-3.86, 3.86-9.62, >9.62 mg/I) and Tn T (-<0.01,0.01- 
0.12, 0.12-0.47, >0.47ug/I) were divided into quartiles and its association to mortality at 1 
year follow up was evaluated by Chi2 and multiple logistic regression analysis adjusting 
for other risk factors. 
Results: Mortality at one year; 
The combination of CRP and TnT enhanced the prognostic information with 1.8% modal- 
it,] for men with both markers in the lowest quartile and 16.3% with both markers in the 
highest. For women the corresponding figures where 1.5% and 21.0%, 
CRP and Troponin T quartiles were independently related to mortality even after adjust- 
ment for other established risk factors in multivariate analysis. 
Conclusion: In unstable coronary syndrome the level of CRP and TnT independently pre- 
dicts a higher long term mortality in both men and women. The combination of the mark- 
ers further enhances the tong-term prognostic insight. 
Mortality at one year 
1 Quartiles 3 4 p- 
2 value(trend) 
Males 
TnT 4.3% 7.8% 7.5% 11.4% <0.001 
CRP 5.0% 5.9% 6.4% 14,4% <0,001 
Females 
TnT 3.3% 7.7% 11.7% 17.4% <0.001 
CRP 5,3% 7.6% 9.0% 13.1% <0.001 
9:15 a.m. 
841-4 Low HDL Cholesterol Is a Strong Independent Risk 
Marker in Non-ST Segment Elevation Acute Coronary  
Syndromes 
Juan J. FuselLi. Javier N. Guetta, Carlos P. Boissonnet, Jos~ G(xlia, Alejandro 
Tettamanzi, Silvia Quiroga, Victor Tortes, CEMIC, Buenos Aires, Argentina. 
Background: Lipids are involved in the genesis of acute coronary syndromes (ACS). 
However the utility of lipid measurements during ACS is not known. 
Objective: To analyze the relationship between usual lipid parameters and markers of 
inflammation or myocardial necrosis and prognosis in patients (p) with non-ST elevation 
acute coronary syndrome (NSTEACS). 
Methods: Prospective cohort study of 106 consecutive p admitted with NSTEACS. Base- 
line clinical and ECG data were recorded and blood samples were collected for: a) Lipid 
measurements: Total cholesterol, LDL-C, HDL-C, and tdglycerides (TG)<12 hs from 
admission, b) cEnT end C reactive protein (CRP) 8 to 24 hs from last chest pain episode. 
End point (EP) was death and/or MI, follow up 371±201 days (maximum 830). 
Results: There was a significant correlation between CRP levels with HDL-C (r = -0.36, 
p=0.002) and TG (r = 0.27; p< 0.05). No association was found between cTnT and any 
lipid level. Lower HDL-C levels were associated with worse prognosis (best cut-off point, 
ROC curve: HDL-C <35 mg/dl, Figure). In a Cox regression model including HDL-C, 
cTnT and CRP, HDL-C <35 mg/dl was the strongest independent predictor of EP (HR 
10.2, CI95% 3.1-33.3; p=.001). 
Conclusion: Low HDL-C levels in NSTEACS are associated with elevated CRP, and con- 
stitute a strong independent predictor for shod- and long-term serious events. Further 
studies are needed to determine the precise role of lipid measurements in this population 
and eventually to include them in risk stratification. 
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841-5 Cl inical  Ut i l i ty of  Myocardial Perfusion Imaging in 
Patients Presenting With Chest  Pain to the Emergency 
Room 
Bharati Shivalkar, Diana Rinkevich, Sanjiv Kaul, Chris Ghaemmaghami, Todd Belcik, 
Kevin Wei, University of Virginia, Charlottesville, Virginia. 
Background: Decreases in coronary driving pressure in the presence of coronary occlu- 
sion or critical coronary stenosis cause capillary derecruitmant which forms the basis for 
resting pedusion defects on myocardial contrast echocardiography (MCE). We therefore 
hypothesized that this technique could be used to distinguish cardiac from non-cardiac 
causes of chest pain in patients presenting to the emergency room (ER), and that peffu- 
sion defects on MCE would provide useful prognostic information. 
Methods: Two hundred patients admitted to the ER with suspected cardiac chest pain 
were included in the study (104 males). Exclusion criteria included age < 40 years, preg- 
nancy or lactation, and allergy to blood components. MCE was performed using continu- 
ous infusion of Optison TM (Mallinckrodt) during intermittent ultraharmonic imaging 
(Agilant). The studies were interpreted by 2 readers blinded to clinical data. Perfusion 
abnormalities present in at least 1 perfusion territory was considered to be positive. 
Results: The MCE studies were interpretable in 153 (77%) patients for all three perfu- 
sion beds. Perlusion defects were seen in 58 patients (38%) on the initial study. The inci- 
dence of cardiac events (including acute myocardial infarction, unstable angina, 
congestive heart failure and cardiac death) was 26% in patients with compared to 3% in 
those without perfusion defects. After a mean follow up of 201 ± 87 days, patients with a 
positive MCE had a significantly higher incidence of myocardial infarction (p<0.001), con- 
gestive heart failure (p=0.O02) and total mortality (p=0.03) compared to patients with nor- 
mal MCE. The incidence of a combined end-point (myocardial infarction, unstable 
angina, heart failure, all-cause death) was also significantly greater in patients with an 
MCE defect (p<0.001). 
Conclusions: MCE can distinguish between cardiac and non cardiac causes of chest 
pain in the ER setting. A positive MCE at the time of patient presentation was associated 
with a significant incidence of early events, and was also highly predictive of a worse 
prognosis during long-term followup. These results may have important clinical implica- 
tions. 
9:45 a.m. 
841-6 Aspirin and Medium Intensity Coumadin Versus Aspirin 
Alone in the Prevention of Reocclusion After 
Successful Thrombolysis for Suspected Acute 
Myocardial Infarction: One-Year Follow-Up of APRICOT- 
2 
Marc A. Brouwer. Paul JP C. van den Bergh, Peter C. Kievit, Wire R M. Aangevaaren, 
Gerdt Veen, Hans E. Luijten, Don P. Hedzbarger, Gerard J H. Uijen, Freek W A. 
Verheugt, UMC Nijmegen, Nijmegen, The Netherlands. 
Background: The APRICOT-2 trial demonstrated that the combination of aspirin with 
medium intensity coumadin (INR 2-3) reduces both angiographic and clinical reocclusion 
in the first three months after successful thrombolysis. We sought to assess whether the 
observed early clinical benefit is sustained at 1 -year follow-up. 
Methods: Patients (n=308) had thrombolytic therapy for suspected acute myocardial inf- 
arction within 6 hours of symptom onset with TIMI 3 flow at angiography < 48 hours. They 
were randomized to either aspirin 80 mg daily, or the combination of aspirin and medium 
intensity coumadin (INR 2-3). Follow-up angiography was scheduled at three months. 
Preliminary one-year clinical follow-up was assessed by Kaplan-Maiar analysis. 
Results: Median follow-up was 305 days(25th,75th percentile 136-507). One-year sur- 
vival without reinfarction was 93% in patients on aspirin combined with coumadin and 
84% in patients on aspirin alone (p<O.01) (figure). Four patients on aspirin and none on 
combination therapy had an ischemic carebrovascular event (p=ns). Total bleeding rates 
were 9% on combination treatment and 4% on aspirin alone (p=ns). 
Conclusions: These preliminary findings suggest that the early clinical benefit of aspirin 
combined with medium intensity coumadin after successful thrombolysis is sustained at 
one-year follow-up. This benefit was achieved with a higher, but acceptable bleeding risk. 
Final data will be presented. 
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